skip to navigation

Recent News

Featured Recent News

News

The ICO Celebrates 160 Years

On 13 September 2017, the International Council of Ophthalmology (ICO) will mark 160 years working to improve eye health… More »

News

Fifteen Years of ICO Fellowships - Program Report

The ICO Fellowships Program helps promising young ophthalmologists from developing countries improve their practical skills… More »

News

ICO Guide to Effective CPD/CME

The ICO Guide to Effective CPD/CME is a new, practical resource covering concepts and questions regarding continuing… More »

Date ICO Member Headline Topic Subspecialty Region
May 2, 2017 Working Together to End Trachoma by 2020

Can we eliminate trachoma by 2020? Cautious optimism was in the air at the April 2017 Neglected Tropical Diseases (NTD) summit in Geneva, Switzerland. Hosted by the World Health Organization (WHO), attendees included Bill Gates, WHO Director-General Margaret Chan, and other leaders in the field, including ICO Board members.

“If we are able to operate on all the patients with trichiasis and prevent them from developing new corneal scarring and blindness, we would end all new cases of blindness from trachoma by 2020,” said ICO President Prof. Hugh Taylor, a featured speaker at the summit.

With this once in a lifetime opportunity to end a major blinding eye disease, the ICO has asked each national ophthalmic society in a country where trachoma is still present to eliminate trichiasis in the next three years by looking at the trichiasis surgery programs in their country and doing whatever they can to mobilize ophthalmologists and harness the necessary resources.


Save to My ICO

Eye Care

Research

August 4, 2017 IAPB Releases Updated Statistics about Blindness and Low Vision

The International Agency for the Prevention of Blindness (IAPB) has released updated statistics for the prevalence of blindness and low vision. These findings, published on 2 August in the Lancet, provide the latest global estimates of the prevalence of blindness and visual impairment in the world.

The paper, published in the Lancet by the Vision Loss Expert Group (VLEG), provides the latest global estimates of the prevalence of blindness and MSVI in the world. By analysing data from 1990 to 2015, the VLEG have employed a sophisticated methodology to produce these detailed estimates, which also includes projections to 2020 for the first time.


Save to My ICO

Advocacy/Vision 2020

Journal/Publication

Research

October 1, 2017 ICO-Allergan Research Fellowship

The ICO is excited to announce a new fellowship opportunity in conjunction with Allergan: The ICO-Allergan Research Fellowship. The opportunity allows the best young ophthalmologists (basic or clinical) from both developed and low-resource countries to continue research in one of eight subspecialties at the university of his or her choice, preferably in another country. The fellowship covers one year of research in glaucoma, neuro-ophthalmology, pediatric ophthalmology, retina, tumours, uveitis, dry eye, or cornea. 

The ICO-Allergan Research Fellowship is awarded to one person per year, with an deadline of 15 January 2018.

Apply Now

View more information on the ICO-Allergan Research Fellowship


Save to My ICO

Fellowship

Research

Stay connected:         Follow us on Instagram

Web site design and web development by D3 Solutions